PsyBio Therapeutics Corp PSYBF

Time to Nibble at More Shares?

[PuerSimia]

Bookworm, we are at .38 cdn today. I bought a few more shares, but starting to have second thoughts about it being a good idea. Today's news release should have supported the price, not pushed it down, don't you think? This is a weird one.

[ValueValue123]

Based on my review of PSYB and its peers (FTRP, CYBN, NUMI, etc.), this seems tremendosuly undervlaued (~C$40m comapred to C$200m+). The RTO financing was done at C$0.35 per share with a raise of C$14.5m, and based on the fact that various publications are highlighing PSYB's annoucement on Berekely Lab from today and Albany Molecular a few weeks back I have no doubt they will continue to

[Bookworm28]

You're not the only one scratching their head PuerSimia. I agree with ValueValue123's comment about the stock being totally undervalued compared to their peers. Looking at the trading data, my current theory is selling by old timers from Leo Acquisitions who paid nothing for their shares, maybe some selling from the guys who participated in the IPO, and no buyers. They're in serious

[ValueValue123]

So far PSYB's operaitonal press release have been substantive compare to what other are putting out. Agreed?  Psilocybin w. Albany Molecular (March 3):https://financialpost.com/globe-newswire/psybio-therapeutics-initiates-pilot-scale-development-of-proprietary-biosynthetic-psilocybin-with-global-contract-research-development-and-manufacturing-organization Norbaeocystin w. Berkely Lab

[Bookworm28]

Hmmm, I liked the share price better before they started telling their story. .365 today is not doing much for my confidence.

[Bookworm28]

What do you guys figure? We at the bottom yet?

[PuerSimia]

I think we might test .33 again in the next couple of days.

[Bookworm28]

Good call PuerSimia. Did you get some at .33? I picked up some BLDP, as you recommended. Popped in and out for some easy money today. Thanks.

[PuerSimia]

Sure did. Not too much for sale, but that's OK.